Nifty Midcap Liquid 15 PB	4.1
Nifty Midcap Liquid 15 PE	34.8
Nifty Midcap Liquid 15 DIV	0.7
Nifty Midcap Liquid 15 EPS	426.9

Nifty Midcap Liquid 15 News and Updates

Keep track of all breaking news on Nifty Midcap Liquid 15 from all sources in a single place.

Load latest

Lupin Ltd.

29 Sep 2025

1981.30

3.66%

Lupin Acquires VISUfarma To Expand European Ophthalmology Market Presence

NDTV Profit

VISUfarma B.V. is headquartered in Amsterdam and it is a specialty pharmaceutical company focused on ophthalmology.

Lupin Ltd. has an average target of 2326.00 from 8 brokers.

Lupin subsidiary Nanomi BV inks pact to acquire Netherlands-based VISUfarma

Business Standard | 29 Sep 2025 1 more

BSE Ltd.

29 Sep 2025

2081.40

2.02%

Sammaan Capital soars 10% on heavy volumes, hits 7-month high; here's why

Business Standard

Till 09:41 AM, a combined 40.01 million equity shares representing 4.8 per cent of total equity of Sammaan Capital changed hands on the NSE and BSE.

Number of MF schemes increased from 149 to 168 in Jun 2025 qtr.

IndusInd Bank Ltd.

29 Sep 2025

743.15

1.03%

IndusInd Bank Price Target: Morgan Stanley Sees 9% Upside As New Management Drives Optimism

NDTV Profit

Morgan Stanley raised the IndusInd Bank price target to Rs 785 from Rs 750.

IndusInd Bank Ltd. has an average target of 811.00 from 11 brokers.

The IndusInd Files Part 1: A Whistleblower, Four Resignations And A Scandal

NDTV Profit | 28 Sep 2025

BSE Ltd.

27 Sep 2025

2081.40

2.02%

BSE Capital Goods, BSE PSU, BSE Industrials, BSE India Manufacturing and BSE CPSE: All set to outperform

Business Line

No matter how the benchmark indices perform, there will always be some sectors that can clearly be the outperformers. Here is our top five sectoral picks that can possibly outperform going forward

Number of MF schemes increased from 149 to 168 in Jun 2025 qtr.

BSE Ltd.

26 Sep 2025

2081.40

2.02%

Markets crash 0.90% as US slaps 100% tariff on branded drugs

Business Line

The pharmaceutical sector bore the brunt of the selling pressure following the tariff announcement, with the BSE Healthcare index correcting approximately 5 per cent for the week

BSE Ltd. has an average target of 2420.67 from 3 brokers.

BSE Smallcap index slips 2%; Symphony, Quess among 25 stocks at 52-week low

Business Standard | 26 Sep 2025

YES Bank Ltd.

26 Sep 2025

21.76

2.40%

Epack Durable: YES Securities sees 50% upside in this 'undervalued' stock

Business Standard

Epack Durable share price: YES Securities values the company at 30x FY28EPS and arrives at a target price of 545

YES Bank Ltd. has gained 25.56% in the last 6 Months

Suzlon Energy Ltd.

25 Sep 2025

55.18

0.24%

Suzlon joins EV 100 initiative; to shift vehicle fleet to EVs by 2035

Business Line

This commitment entails Suzlon electrifying 655 vehicles across its operations, covering both owned and leased vehicles in certain categories

Suzlon Energy Ltd. has lost -30.80% in the last 1 Year

Dixon Technologies (India) Ltd.

25 Sep 2025

16453.00

0.80%

Dixon Technologies shares rise as UBS upgrades it to buy rating, sees 27% upside

Economic Times

Dixon Technologies shares: UBS upgraded the stock to a Buy' with a 23,000 target, implying ~27% upside. UBS highlighted Dixon's expansion into non-semiconductor smartphone components, expecting EBITDA margins to rise 110 bps by FY28, outperforming consensus estimates.

Dixon Technologies (India) Ltd. is trading above its 200 day SMA of 15780.3

'Buy' Dixon Technologies, Says UBS After Stock Upgrade Check Price Target, Key Stock DriversAndMore

NDTV Profit | 25 Sep 2025 1 more

Lupin Ltd.

24 Sep 2025

1981.30

3.66%

Lupin gets tentative nod from USFDA for generic HIV treatment drug

Business Standard

Pharma major Lupin Ltd on Wednesday said it has received tentative approval from the US health regulator for its generic version of Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets used to treat human immunodeficiency virus (HIV) infection. The approval by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application for Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets of strength 50 mg/200 mg/25 mg, Lupin said in a regulatory filing. This product would be manufactured at Lupin's Nagpur facility, it added. Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets, 50 mg/200 mg/25 mg are bioequivalent to Biktarvy Tablets, 50 mg/200 mg/25 mg of Gilead Sciences, Inc., and indicated for the treatment of human immunodeficiency virus infection in adults and pediatric patients weighing at least 25 kg, it added. Citing IQVIA MAT July 2025 data, Lupin said the Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets (Biktarvy) had

Lupin Ltd. is trading below its 200 day SMA of 2019.7

Suzlon Energy Ltd.

24 Sep 2025

55.18

0.24%

Suzlon to transition entire vehicular fleet to electric vehicles by 2035

Business Standard

Renewable energy solutions provider Suzlon on Wednesday said it will transition its entire vehicular fleet to electric mobility by 2035. After committing to power all its facilities with 100 per cent renewable energy by 2030, Suzlon has taken another bold step in its sustainability journey by joining the global EV100 initiative of Climate Group, a company statement said. As part of this, Suzlon will transition its entire fleet to electric vehicles by 2035, further reducing carbon emissions, lowering fuel consumption, and strengthening India's march towards Net Zero, it stated. EV100 is a global initiative by Climate Group that brings together leading companies committed to accelerating the transition to electric vehicles and making electric transport the new normal by 2030. This commitment entails Suzlon electrifying 655 vehicles across its operations, covering both owned and leased vehicles in the 3.5T and 3.57.5T categories. This initiative directly supports the reduction of Sco

Suzlon Energy Ltd. is trading below all available SMAs

Is Nifty Midcap Liquid 15 worth buying?

31 Votes:

Buy 74.19%

Sell 12.9%

Hold 12.9%

28.83% Gain from 52W Low

Nifty Midcap Liquid 15 PB

Nifty Midcap Liquid 15 PE

Nifty Midcap Liquid 15 DIV

Nifty Midcap Liquid 15 EPS

Nifty Midcap Liquid 15 News and Updates

Keep track of all breaking news on Nifty Midcap Liquid 15 from all sources in a single place.